Raloxifene is a selective estrogen-receptor ... There is still much to be learned about SERMs and their mechanism of action. This article reviews what is currently known about the pharmacology ...

Background: Both raloxifene and bisphosphonates are indicated for the prevention and treatment of postmenopausal osteoporosis, however these medications have different efficacy and safety profiles.

Raloxifene is a selective estrogen receptor modulator used for prevention and treatment of postmenopausal osteoporosis. It acts as an agonist of estrogen in bone but an antagonist in other tissues ...

Cancel anytime. Dr. Roach: I am an 85-year-old woman in relatively good health. I had been taking raloxifene for approximately 45 years. My doctor at the time said that since I had a complete ...